Estrogen intake and copper depositions: Implications for alzheimer's disease?

Case Reports in Neurology

Volumn 6, Issue 2, 2014, Pages 181-187

  Amtage, Florian ^a   Birnbaum, Dzelila ^a   Reinhard, Thomas ^a   Niesen, Wolf Dirk ^a   Weiller, Cornelius ^a   Mader, Irina ^a   Meyer, Philipp T ^a   Rijntjes, Michel ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Alzheimer's disease; Ceruloplasmin; Copper; Estrogen; 11C PIB PET

Indexed keywords

CERULOPLASMIN; COPPER; ESTRADIOL; FLUORODEOXYGLUCOSE F 18; MENKES PROTEIN; MESSENGER RNA; PITTSBURGH COMPOUND B;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; CASE REPORT; CATARACT; COPPER BLOOD LEVEL; CORNEA DISEASE; CORNEA STROMA; DESCEMET MEMBRANE; ESSENTIAL TREMOR; ESTROGEN THERAPY; FEMALE; HUMAN; KAYSER FLEISCHER RING; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PTERYGIUM; SLIT LAMP; SUSCEPTIBILITY WEIGHTED IMAGING;

EID: 84921446791     PISSN: 1662680X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000363688     Document Type: Article

References (17)

1. Aldave AJ, King JA, Kim BT, Hopp L: Corneal copper deposition associated with chronic lymphocytic leukemia. Am J Ophthalmol 2006;142:174-176.
2. Tauber J, Steinert RF: Pseudo-Kayser-Fleischer ring of the cornea associated with non-Wilsonian liver disease. A case report and literature review. Cornea 1993;12:74-77.
3. Taly AB, Meenakshi-Sundaram S, Sinha S, Swamy HS, Arunodaya GR: Wilson disease: description of 282 patients evaluated over 3 decades. Medicine (Baltimore) 2007;86:112-121.
4. Carruthers ME, Hobbs CB, Warren RL: Raised serum copper and caeruloplasmin levels in subjects taking oral contraceptives. J Clin Pathol 1966;19:498-500.
5. O'Leary JA, Spellacy WN: Serum copper alteration after ingestion of an oral contraceptive. Science 1968;162:682.
6. Garmizo G, Frauens BJ: Corneal copper deposition secondary to oral contraceptives. Optom Vis Sci 2008;85:E802-E807.
7. Orlin A, Orlin SE, Makar GA, Bunya VY: Presumed corneal copper deposition and oral contraceptive use. Cornea 2010;29:476-478.
8. Machado A, Chien HF, Deguti MM, Cancado E, Azevedo RS, Scaff M, Barbosa ER: Neurological manifestations in Wilson's disease: report of 119 cases. Mov Disord 2006;21:2192-2196.
9. Louro MO, Cocho JA, Tutor JC: Assessment of copper status in pregnancy by means of determining the specific oxidase activity of ceruloplasmin. Clin Chim Acta 2001;312:123-127.
10. Hardman B, Michalczyk A, Greenough M, Camakaris J, Mercer JF, Ackland ML: Hormonal regulation of the Menkes and Wilson copper-transporting ATPases in human placental Jeg-3 cells. Biochem J 2007;402:241-250.
11. van den Berghe PV, Klomp LW: New developments in the regulation of intestinal copper absorption. Nutr Rev 2009;67:658-672.
12. Bucossi S, Mariani S, Ventriglia M, Polimanti R, Gennarelli M, Bonvicini C, Pasqualetti P, Scrascia F, Migliore S, Vernieri F, Rossini PM, Squitti R: Association between the c. 2495 AG ATP7B polymorphism and sporadic Alzheimer's disease. Int J Alzheimers Dis 2011;2011:973692.
13. Walter U, Krolikowski K, Tarnacka B, Benecke R, Czlonkowska A, Dressler D: Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease. Neurology 2005;64:1726-1732.
14. Bucossi S, Ventriglia M, Panetta V, Salustri C, Pasqualetti P, Mariani S, Siotto M, Rossini PM, Squitti R: Copper in Alzheimer's disease: a meta-analysis of serum,plasma, and cerebrospinal fluid studies. J Alzheimers Dis 2011;24:175-185.
15. Squitti R, Salustri C: Agents complexing copper as a therapeutic strategy for the treatment of Alzheimer's disease. Curr Alzheimer Res 2009;6:476-487.
16. Ma QF, Li YM, Du JT, Kanazawa K, Nemoto T, Nakanishi H, Zhao YF: Binding of copper (II) ion to an Alzheimer's tau peptide as revealed by MALDI-TOF MS, CD, and NMR. Biopolymers 2005;79:74-85.
17. Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH; Women's Health Initiative Memory Study: Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004;291:2947-2958.